Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting

Journal of Investigational Allergology and Clinical Immunology

Volumn 19, Issue 3, 2009, Pages 195-203

  Yonekura, S ^a   Okamoto, Yoshitaka ^a   Okubo, K ^b   Okawa, T ^a   Gotoh, M ^c   Suzuki, H ^b   Kakuma, T ^d   Horiguchi, S ^a   Hanazawa, T ^a   Konno, A ^e   Okuda, M ^b,f  

^a CHIBA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Southern Tohoku General Hospital and Southern Tohoku Research Institute for Neuroscience   (Japan)

^f Japan Allergy and Asthma Clinic   (Japan)

Author keywords

Allergic rhinitis; Cedar pollinosis; Early intervention; Leukotriene receptor antagonist

Indexed keywords

CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; LORATADINE; PLACEBO; PRANLUKAST; TETRYZOLINE;

ABDOMINAL PAIN; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CEDAR POLLINOSIS; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EVENING DOSAGE; EYE DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NOSE CONGESTION; NOSE DISEASE; PATIENT MONITORING; POLLEN ALLERGY; QUALITY OF LIFE; RHINORRHEA; SEASONAL VARIATION; SNEEZING;

ADULT; CHROMONES; CRYPTOMERIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; POLLEN; QUALITY OF LIFE; RHINITIS, ALLERGIC, SEASONAL;

EID: 67651160921     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Grossman J. One airway, one disease. Chest. 1997;111:S11-16.
2. Okuda M. Epidemiology of Japanese cedar pollinosis throughout Japan. Ann Allergy Asthma Immunol. 2003;91:288-296 (Pubitemid 37174163)
3. Practical Guideline for the Management of Allergic Rhinitis in Japan - Perennial rhinitis and pollinosis - 2005 Edition (the fifth revision), Life Science Publishing Co., Ltd., Tokyo, 2005.
4. Delaunay JJ, Sasajima H, Okamoto Y, Yokota M. Side-by-side comparison of automatic pollen counters for use in pollen information systems. Ann Allergy Asthma Immunol. 2007;98:553-558 (Pubitemid 46933860)
5. Lipworth BJ. Emerging role of antileukotriene therapy in allergic rhinitis. Clin Exp Allergy. 2001;31:1813-1821 (Pubitemid 34014726)
6. Meltzer EO. Clinical evidence for antileukotriene therapy in the management of allergic rhinitis. Ann Allergy Asthma Immunol. 2002;88(4 Suppl 1):23-29
7. Peters-Golden M, Gleason MM, Togias A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy. 2006,36:689-703. (Pubitemid 43972964)
8. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol. 2003;111:S18-36. (Pubitemid 36135509)
9. Peters-Golden M, Henderson WR Jr. The role of leukotrienes in allergic rhinitis. Ann Allergy Asthma Immunol. 2005;94:609-618
10. Wilson AM, O'Byrne PM, Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med. 2004;116:338-344 (Pubitemid 38230294)
11. Rodrigo GJ, Yanez A. The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials. Ann Allergy Asthma Immunol. 2006;96:779-786 (Pubitemid 43911792)
12. Pullerits T, Praks L, Ristioja V, Lotvall J. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2002;109:949-955 (Pubitemid 34634304)
13. Konno A, Yamagoshi T, Usui S. Clinical assessment of ONO-1078 (pranlukast hydrate) against perennial allergic rhinitis - Clinical pharmacological study using airway resistance in the nasal cavity as an indicator - (A double blind comparative study using placebo as a control drug). J Clin Ther Med. 1997;13:1921-1939
14. Okuda M, Ohkubo K, Goto M, Okamoto H, Konno A, Baba K, Ogino S, Enomoto M, Imai T, So N, Ishikawa Y, Takenaka Y, Manndai T, Crawford B. Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires. Acta Otolaryngol. 2005;125:736-744 (Pubitemid 41044320)
15. Okubo K, Gotoh M, Shimada K, Ritsu M, Kobayashi M, Okuda M. Effect of fexofenadine on the quality of life of Japanese cedar pollinosis patients. Allergology International. 2004;53:245-254 (Pubitemid 39312320)
16. Okubo K, Gotoh M, Shimada K, Ritsu M, Okuda M, Crawford B. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. Int Arch Allergy Immunol. 2005;136:148-154 (Pubitemid 40463239)
17. Keskin O, Alyamac E, Tuncer A, Dogan C, Adalioglu G, Sekerel BE. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis? Pediatr Allergy Immunol. 2006;17:259-268
18. Sander C, Rajakulasingam K. Leukotriene receptor antagonists for the treatment of allergic rhinitis. Clin Exp Allergy. 2002;32:4-7. (Pubitemid 34226920)
19. Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol. 2000;105:917-922 (Pubitemid 30324400)
20. Nayak AS, Philip G, Lu S, Malice MP, Reiss TF; Montelukast Fall Rhinitis Investigator Group. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol. 2002;88:592-600. (Pubitemid 36183813)
21. Barnes PJ. New directions in allergic diseases: mechanism-based anti-inflammatory therapies. J Allergy Clin Immunol. 2000;106:5-16.
22. Tomari S, Matsuse H, Machida I, Kondo Y, Kawano T, Obase Y, Fukushima C, Shimoda T, Kohno S. Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumor necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy. 2003;33:795-801. (Pubitemid 36760512)
23. Parameswaran K, Watson R, Gauvreau GM, Sehmi R, O'Byrne PM. The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma. Am J Respir Crit Care Med. 2004;169:915-920 (Pubitemid 38457317)
24. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S223-9.
25. Borres MP, Brakenhielm G, Irander K. How many teenagers think they have allergic rhinoconjunctivitis and what they do about it. Ann Allergy Asthma Immunol. 1997,78:29-34. (Pubitemid 27058318)
26. Cox LS, Linnermann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. 2006;117:1021-1035
27. Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis. Int Arch Allergy Immunol. 2008;146:76-84. (Pubitemid 351562946)